scispace - formally typeset
M

Meme Wijesinghe

Researcher at Wellington Management Company

Publications -  32
Citations -  1803

Meme Wijesinghe is an academic researcher from Wellington Management Company. The author has contributed to research in topics: Asthma & Oxygen therapy. The author has an hindex of 20, co-authored 29 publications receiving 1331 citations. Previous affiliations of Meme Wijesinghe include Wellington Hospital & University of Otago.

Papers
More filters
Journal ArticleDOI

Systematic review of studies of the effect of hyperoxia on coronary blood flow.

TL;DR: Hyperoxia from high-concentration oxygen therapy causes a marked reduction in coronary blood flow and myocardial oxygen consumption, and these physiologic effects may have the potential to cause harm and are relevant to the use of high- Concentrations oxygen therapy in the treatment of cardiac and other disorders.
Journal ArticleDOI

Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study.

Clark D Russell, +355 more
TL;DR: The International Severe Acute Respiratory and Emerging Infections Consortium (ISARIC) WHO Clinical Characterisation Protocol UK (CCP-UK) study as discussed by the authors is an ongoing, prospective cohort study recruiting inpatients from 260 hospitals in England, Scotland, and Wales, conducted by the ISARIC Coronavirus Clinical Characterization Consortium.
Journal ArticleDOI

Routine use of oxygen in the treatment of myocardial infarction: systematic review

TL;DR: The limited evidence that does exist suggests that the routine use of high-flow oxygen in uncomplicated MI may result in a greater infarct size and possibly increase the risk of mortality.
Journal ArticleDOI

Meta-analysis of the risk of mortality with salmeterol and the effect of concomitant inhaled corticosteroid therapy

TL;DR: There is no evidence that combination salmeterol/fluticasone propionate therapy is associated with an increased risk of asthma mortality, although this interpretation is limited by the low statistical power of available studies.
Journal ArticleDOI

Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK.

Chloe I Bloom, +339 more
TL;DR: In this paper, the effect of inhaled corticosteroid use in patients admitted to hospital with COVID-19 with underlying respiratory conditions was examined. But, the results were limited to patients aged 50 years and older and not for those with chronic pulmonary disease.